Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic

Single mutation at the amino acid position 627 of PB2 that leads to increased virulence of an H5N1 avian influenza virus during adaptation in mice can be compensated by multiple mutations at other sites of PB2

(2009) Junwei Li et al.   VIRUS RESEARCH

Novel Druggable Hot Spots in Avian Influenza Neuraminidase H5N1 Revealed by Computational Solvent Mapping of a Reduced and Representative Receptor Ensemble

(2008) Melissa R. Landon et al.   Chemical Biology & Drug Design

Theoretical analysis of binding specificity of influenza viral hemagglutinin to avian and human receptors based on the fragment molecular orbital method

(2008) Tatsunori Iwata et al.   COMPUTATIONAL BIOLOGY AND CHEMISTRY

Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza

(2008) Andrew W. Hill et al.   INFECTION GENETICS AND EVOLUTION

Recent Avian H5N1 Viruses Exhibit Increased Propensity for Acquiring Human Receptor Specificity

(2008) James Stevens et al.   JOURNAL OF MOLECULAR BIOLOGY

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China

(2008) Hua Wang et al.   LANCET

Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007

(2008) Xiu-Feng Wan et al.   PLoS One

The development and genetic diversity of H5N1 influenza virus in China, 1996–2006

(2008) L. Duan et al.   VIROLOGY

Evolutionary Dynamics and Emergence of Panzootic H5N1 Influenza Viruses

(2008) Dhanasekaran Vijaykrishna et al.   PLoS Pathogens

Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China

(2007) Guimei He et al.   ANTIVIRAL RESEARCH